key: cord-0698987-b9gfalwb
authors: Zimmerman, Asha
title: Expecting the unexpected: COVID‐19 in Kidney Transplant Recipients within United Network for Organ Sharing Region 1
date: 2020-10-01
journal: Transpl Int
DOI: 10.1111/tri.13757
sha: 5c51d23f9c19f577b4d751149236fecb40c983ad
doc_id: 698987
cord_uid: b9gfalwb

There are numerous case reports and a handful of single(1–5) center studies reporting on COVID‐19 in kidney transplant recipients. Most reports arise from the epicenters of where the SARS‐CoV‐2 virus was first detected such as New York City(1,2,5) and Europe(3,4). We in UNOS Region 1 experienced COVID‐19 weeks to a month later and questioned whether our experience was different. The programs within UNOS Region 1 have had a long history of sharing information in an attempt to mitigate the effect of viruses on our patients.

This article is protected by copyright. All rights reserved patients (3.7%) were asymptomatic. One-hundred and thirty-seven required hospital admission (72.5%). Of those, 46 (24.3%) required ICU admission and 39 (20.6%) required intubation. Kidney dysfunction, as defined by KDIGO guidelines was reported in 29 (15.3%). Twelve (6.4%) patients required dialysis and 5 (2.7%) experienced graft loss. Twenty-three (12.2%) patients died of COVID-19 or COVID-19 related complications. There were 22 (11.6%) transplant recipients diagnosed with COVID-19 within 1 year of their transplant. Six centers (46%) reported that they were currently altering their deceased donor transplant decisions, offer selection or induction plans due to COVID-19 and all but one center (92%) was performing living donor kidney transplantation.

While this survey addresses outcomes and incidence, it lacks the detailed information necessary to make individual management decisions. The results suggest that the incidence and severity of COVID-19 in kidney transplant recipients in our UNOS Region are lower than those in more densely populated areas. Further, the incidence described in kidney transplant recipients in this study somewhat unexpectedly mimics those reported in the general and pediatric populations.

To our knowledge, this is the largest report of COVID-19 infected kidney transplant recipients and their outcomes since the start of the pandemic.

Although still high, the cumulative mortality rate in Region 1 was 12.2% which is lower than the 13-30% 1-5 reported by the initial epicenters. Most importantly, this mortality rate might offer reassurance when compared to the reported mortality rate of maintenance dialysis patients of 28-31% 6-8 .

While comparisons are challenging because of the rapid learning curve and changes in practice patterns as the pandemic has progressed, ongoing regional differences will be likely and individual centers need to make informed decisions based upon their patients' risk within their specific regions. These decisions would benefit from more robust data through a national prospective registry.

This article is protected by copyright. All rights reserved Table 1 Accepted Article

This article is protected by copyright. All rights reserved 

COVID-19 and kidney transplantation

COVID-19 in kidney transplant recipients

A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia

COVID-19 infection in kidney transplant recipients

Kidney allograft recipients , immunosuppression , and coronavirus disease-2019 : a report of consecutive cases from a New York City transplant center

COVID-19 Outbreak in a Hemodialysis Center: A Retrospective Monocentric Case Series

COVID-19: clinical course and

This article is protected by copyright. All rights reserved